Top Markets
#1 GEKKO GEKKO +43.17%
#2 TENDIES TENDIES +39.20%
#3 ADO Protocol ADO Protocol +38.64%
#4 Pons Pons +36.87%
#5 Helium Helium +27.97%
#6 Prom Prom +25.93%
#7 龙虾 (Lobster) 龙虾 (Lobster) +20.86%
#8 Nillion Nillion +18.38%
#9 o1.exchange o1.exchange +17.72%
#10 Main Street Yield Main Street Yield +17.48%
Coin of the day
GEKKO GEKKO
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Gubra A/S Gubra A/S

Gubra A/S

GUBRA
Hisse Senetlerindeki Sıralama #9438
Gubra A/S is a biotechnology firm engaged in two core activities: offering... Gubra A/S is a biotechnology firm engaged in two core activities: offering contract research organization (CRO) services for pre-clinical development, and advancing its own internal early-stage drug and target discovery initiatives. Its CRO division provides specialized pre-clinical research and development support to companies in the pharmaceutical and biotechnology sectors. These services encompass a wide range of capabilities, including in vivo pharmacology, tissue analysis, various assay development, molecular pharmacology, bioanalytical testing, next-generation sequencing (NGS), and both two-dimensional and three-dimensional imaging techniques. Established in 2008, the company has its headquarters in Horsholm, Denmark.
Hisse Fiyatı
$61.73
Son senkronizasyon: 2026-08-28
Piyasa Değeri
$1.01B
Değişim (1 gün)
-1.02%
Değişim (1 yıl)
5.10%
Ülke
DK
Ticaret Gubra A/S (GUBRA)

Kategori

Healthcare
Gubra A/S (GUBRA) için kazanç
2026 itibarıyla kazanç TTM: 0
Gubra A/S şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Gubra A/S için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH